Article (Published version) (401 Kb) - 
Free access
Highlights
More informations
Professional Article
unige:41823 
 |
Variant GADL1 and response to lithium in bipolar I disorder |
|
| Authors | ||
| Collaboration | ||
| Published in | New England Journal of Medicine. 2014, vol. 370, no. 19, p. 1857-9 | |
| Keywords | Antimanic Agents/therapeutic use — Bipolar Disorder/genetics — Carboxy-Lyases/genetics — Female — Humans — Lithium/therapeutic use — Male — Polymorphism, Single Nucleotide | |
| Identifiers | PMID: 24806176 | |
| Full text | ||
| Structures | ||
| Research group | Thérapeutiques des Troubles de l'Humeur et Anxieux (689) | |
| Citation (ISO format) | HOU, Liping et al. Variant GADL1 and response to lithium in bipolar I disorder. In: New England Journal of Medicine, 2014, vol. 370, n° 19, p. 1857-9. doi: 10.1056/NEJMc1401817#SA4 https://archive-ouverte.unige.ch/unige:41823 |
353 hits 
34 downloads 
Contact an author
Update